Lv1
88 积分 2024-02-05 加入
Applicability of phase 3 trial selection criteria to real-world transthyretin amyloid cardiomyopathy patients
3天前
已完结
Mapping Advantages and Challenges in Analytical Development for Fixed Dose Combination Products, a Review
10天前
已完结
PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
19天前
已完结
Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine
1个月前
已完结
Single‐Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N‐acetylgalactosamine–Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects
1个月前
已完结
Angiopoietin-Like 3 Antibody Therapy in Patients With Suboptimally Controlled Hyperlipidemia
1个月前
已完结
Real-world treatment management in hereditary transthyretin amyloidosis – an experience report and proposal for therapy switch decision criteria
1个月前
已完结
Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies
1个月前
已完结
A Qualitative Study to Explore the Patient Experience of Hypertriglyceridemia-related Acute Pancreatitis
1个月前
已完结
Overcoming Barriers to Developing and Implementing Novel Therapies for Hypertension
1个月前
已完结
皖公网安备34019202002308
